Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATHLOS: BGF MDI vs BFF MDI and Placebo in COPD
NCT06067828Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2023
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of Breztri Aerosphere in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Oct 2023; status: completed.
02
Drugs
Breztri Aerosphere
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06067828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06067828.